Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Credit Enhanced Corts Trust Aon Capital A | KTN | 28. mar 2025 | 26.40 | +0.15 |
Credit Suisse Ag | SLVO | 28. mar 2025 | 82.42 | -0.18 |
Credit Suisse Ag | GLDI | 28. mar 2025 | 161.75 | +0.15 |
Credit Suisse Asset Management Income Fund | CIK | 28. mar 2025 | 2.90 | 0.00 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | 28. mar 2025 | 60.50 | -0.36 |
Credit Suisse High Yield Bond Fund | DHY | 28. mar 2025 | 2.14 | +0.47 |
Credo Technology | CRDO | 28. mar 2025 | 40.51 | -4.53 |
Crescent Capital BDC | CCAP | 28. mar 2025 | 17.52 | -1.52 |
Crescent Energy | CRGY | 28. mar 2025 | 11.14 | -1.15 |
Cresud A ADR | CRESY | 28. mar 2025 | 11.43 | -1.04 |
Crexendo | CXDO | 28. mar 2025 | 5.12 | -5.36 |
CRH | CRH | 28. mar 2025 | 88.14 | -4.34 |
Cricut A | CRCT | 28. mar 2025 | 5.16 | -1.15 |
Crinetics Pharmaceuticals | CRNX | 28. mar 2025 | 34.73 | -0.49 |
CRISPR Therapeutics | CRSP | 28. mar 2025 | 36.99 | -2.76 |
Criteo ADR | CRTO | 28. mar 2025 | 35.02 | -4.44 |
Critical Metals | CRML | 28. mar 2025 | 1.40 | +1.45 |
Crocs | CROX | 28. mar 2025 | 105.99 | -4.16 |
Cronos Group | CRON | 28. mar 2025 | 1.79 | -2.19 |
Cross Country Healthcare | CCRN | 28. mar 2025 | 15.00 | -0.73 |
Cross Timbers Royalty Royalty Trust | CRT | 28. mar 2025 | 12.33 | +4.85 |
CrossAmerica Partners LP Unit | CAPL | 28. mar 2025 | 24.33 | +0.45 |
CrowdStrike A | CRWD | 28. mar 2025 | 357.11 | -2.58 |
Crown Castle | CCI | 28. mar 2025 | 103.60 | +0.98 |
Crown Crafts | CRWS | 28. mar 2025 | 3.69 | -1.73 |
Crown ElectroKinetics | CRKN | 28. mar 2025 | 3.42 | 0.00 |
Crown Holdings | CCK | 28. mar 2025 | 88.20 | -1.81 |
Crown LNG | CGBS | 28. mar 2025 | 0.20 | -11.55 |
Cryo-Cell International | CCEL | 28. mar 2025 | 6.30 | -1.93 |
CryoPort | CYRX | 28. mar 2025 | 6.09 | -2.40 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.